Generic Drug Price-Fixing Settlement, Check If You Qualify — State of Connecticut, et al. v. Aurobindo Pharma USA, Inc., et al., No. 3:16-cv-02056

There’s more than $96 million waiting for people who bought certain generic prescription drugs — if you bought one between May 1, 2009, and December 31, 2019. Six drug manufacturers agreed to pay after a coalition of 48 attorneys general accused them of secretly fixing prices on more than 100 generic drugs. You have until March 8, 2027, to file.

Generic Drug Price-Fixing Settlement — Key Facts

Field	Detail
Settlement Amount	More than $96,000,000 combined (some outlets cite $96.5M or $99M; this article uses the figure from the New York Attorney General’s own September 22, 2026 announcement)
Claim Deadline	March 8, 2027
Who Qualifies	Individuals who bought a qualifying generic prescription drug in the U.S. between May 1, 2009, and December 31, 2019, and currently live in one of 48 participating jurisdictions
Estimated Payout	UNVERIFIED — the coalition’s own announcement explicitly did not state how much any individual claimant might receive
Proof Required (Yes/No)	UNVERIFIED — this article could not access the official FAQ directly (site blocked automated access); some reporting references a no-proof self-attestation option, but full claim-form mechanics could not be independently confirmed
Settlement Status	Distribution plan preliminarily approved; final approval hearings still pending
Court & Case Number	U.S. District Court for the District of Connecticut — State of Connecticut, et al. v. Aurobindo Pharma USA, Inc., et al., No. 3:16-cv-02056, plus two related multistate actions
Law Alleged	State antitrust laws (price-fixing, bid-rigging, market allocation)
Administrator	Contact via [email protected] or 1-866-290-0182
Official Claim Site	AGGenericDrugs.com (see note on sourcing below)
Last Updated	September 26, 2026

Who Are the Defendants and Why Are They Being Sued for Price-Fixing?

Six generic drug manufacturers have settled so far: Apotex Corp., Heritage Pharmaceuticals Inc. and its parent Emcure Pharmaceuticals Ltd., Bausch Health US LLC and Bausch Health Americas Inc., Lannett Company Inc., and Glenmark Pharmaceuticals Inc. USA. A coalition of 48 state attorneys general accused these companies, alongside dozens of others still fighting the case, of coordinating prices on everyday medications instead of competing for your business — the exact behavior antitrust law exists to stop.

What Did These Companies Do to Consumers Between 2009 and 2019?

The lawsuits allege these manufacturers ran a broad, coordinated conspiracy to fix prices, avoid competition, and rig bids on more than 100 generic drugs — everything from antibiotics and antidepressants to contraceptives and anti-inflammatories. According to New York Attorney General Letitia James’s office, industry executives met at industry dinners, “girls’ nights out,” lunches, cocktail parties, and golf outings, coordinating through phone calls, emails, and texts, using phrases like “fair share” and “playing nice in the sandbox” to describe their arrangement. In some cases, coordinated price increases topped 1,000% — the office points to Digoxin, a heart medication made by Heritage, which tripled in price.

All six settling companies deny wrongdoing. Settling is a business decision to end costly litigation, not a court finding of guilt.

That tripling in the price of a heart medication is the kind of detail that makes this case less abstract — it’s the difference between an affordable prescription and one that isn’t.

Who Qualifies for the Generic Drug Price-Fixing Settlement?

Here’s exactly how to know if this case includes you.

• Anyone who bought — or paid a copay, coinsurance, or the full cash price for — a qualifying generic prescription drug in the United States, and not for resale
• Purchases made between May 1, 2009, and December 31, 2019
• Current residents of one of the 48 participating jurisdictions: 44 states plus the District of Columbia, Puerto Rico, the U.S. Virgin Islands, and the Northern Mariana Islands
• People who paid through insurance still qualify — the portion you personally paid (copay or coinsurance) counts

You likely do not qualify if:

• You bought the drugs outside the United States or for resale
• You’re an employee of one of the defendant companies or an affiliate
• You currently live in one of the six non-participating jurisdictions: Alabama, Arkansas, Hawaii, Louisiana, Missouri, or Texas

Consumers in Non-Participating States — Are You Still Covered?

Some reporting suggests residents of Alabama, Arkansas, Hawaii, Louisiana, Missouri, and Texas may still have limited eligibility tied to specific individual settlements (such as Apotex), separate from the main 48-jurisdiction coalition. This article could not independently confirm those state-specific carve-outs from the official settlement notice, so if you live in one of these six states, it’s worth checking directly at the claim site or calling the administrator rather than assuming you’re excluded.

Not sure if you qualify? A free consultation with a consumer rights attorney can help you check before the March 8, 2027 deadline.

How Much Can Generic Drug Settlement Class Members Get?

The coalition’s own announcement did not state how much any individual claimant might receive, and this article could not verify a payout estimate from a primary source. What is confirmed: one piece of the fund — the Glenmark settlement alone, worth more than $29 million — breaks down as roughly $20.7 million set aside to pay consumers and about $8.9 million for administration and the states’ litigation costs. That pattern, a meaningful share going to administration before anything reaches a mailbox, is normal for a settlement like this.

What This Means for Your Check

Payment size will depend on how many people file valid claims against the available fund. More filers generally means smaller individual checks. Nobody — including the settlement administrator — can tell you a specific number before the claims window closes.

Payments over $600 may appear on a 1099. Check with a tax professional about how a settlement payment could affect your taxes.

Nobody knows the exact number yet, and anyone who tells you a specific dollar figure right now is guessing.

How to File Your Generic Drug Settlement Claim — Step by Step

1. Go to the official claim site: AGGenericDrugs.com
2. Confirm you bought a listed generic drug between May 1, 2009, and December 31, 2019 — the full drug list is on the site
3. Fill in your purchase and contact information as directed by the claim form
4. Submit and save your confirmation
5. Watch your email or mail — the settlement administrator will contact you if anything else is needed
6. If you can’t file online, request a paper form by emailing [email protected] or calling 1-866-290-0182

⚠️ 163 days left as of this writing — file now at AGGenericDrugs.com.

Should Generic Drug Settlement Class Members Opt Out or Object?

What Opting Out Actually Means

Some reporting indicates an earlier opt-out deadline of October 15, 2026 applied to excluding yourself from the underlying settlements with the six companies, while a separate opt-out window tied to the plan for distributing the money runs later. This article could not fully reconcile these two distinct deadlines from a single primary source, so if you’re considering opting out of anything related to this case, confirm the current deadline directly with the settlement administrator or a class action attorney before acting.

How to Object

Objecting means staying in and telling the court in writing what you don’t like about the settlement or the distribution plan. Given the layered nature of this case — three separate lawsuits, six settling companies, and a distribution plan approved separately from the settlements themselves — a class action lawsuit attorney can help you determine which deadline applies to your situation.

Generic Drug Price-Fixing Settlement — Key Dates

Milestone	Date
First Lawsuit Filed (Heritage + 17 others, 15 drugs)	2016
Second Lawsuit Filed (22 manufacturers)	2019
Third Lawsuit Filed (26 companies, 80 topical drugs)	2020
Apotex and Heritage Settlements ($49.1 million)	2024
Bausch and Lannett Settlements ($17.85 million)	February 2, 2026
Glenmark Pharmaceuticals Settlement (more than $29 million)	2026
Distribution Plan Preliminarily Approved	September 2026
Claim Filing Deadline	March 8, 2027
Final Hearing on Allocation/Distribution Plan	UNVERIFIED — one source cites September 8, 2027, not independently confirmed
Expected Payment Date	UNVERIFIED — payments follow final court approval and completed claim processing

Generic Drug Price-Fixing Settlement — Frequently Asked Questions

Do I need a lawyer to file a claim?

 No. The claim form at AGGenericDrugs.com is built for consumers to file directly, and filing is free. Never pay anyone to file this claim for you.

Is this settlement legitimate? 

Yes. It stems from lawsuits filed by a coalition of 48 state attorneys general, led in part by New York Attorney General Letitia James, and the U.S. District Court for the District of Connecticut has preliminarily approved the plan to distribute the money.

When will settlement payments be sent? 

UNVERIFIED — no specific payment date has been announced. Payments follow final court approval and completed claim processing.

What if I missed the claim deadline? 

If you miss March 8, 2027, you generally lose the right to a payment from this fund.

Will my settlement payment go on a 1099?

 Possibly. Payments over $600 may be reported on a 1099. Check with a tax professional about your specific situation.

Does this settlement mean my generic medication isn’t safe? 

No. This case is entirely about pricing — whether you paid more than you should have because competitors allegedly agreed not to compete. It has nothing to do with drug safety or effectiveness. Don’t stop taking a medication because of this settlement; talk to your doctor about any medication decision.

Are companies like Teva and Pfizer part of this settlement? 

No. They’re named as defendants in the states’ ongoing lawsuits, but they have not settled this case, and nothing has been proven against them in court here. Only Apotex, Heritage, Emcure, Bausch, Lannett, and Glenmark have settled so far.

Sources Used in This Generic Drug Price-Fixing Article

• New York Attorney General — “Attorney General James Encourages New Yorkers to Claim Compensation for Inflated Generic Drug Prices,” September 22, 2026: https://ag.ny.gov/press-release/2026/attorney-general-james-encourages-new-yorkers-claim-compensation-inflated
• Washington State Attorney General — “AG Brown announces $17.85 million in settlements in ongoing drug price-fixing conspiracy case,” February 2, 2026: https://www.atg.wa.gov/news/news-releases/ag-brown-announces-1785-million-settlements-ongoing-drug-price-fixing-conspiracy

Researched and written by Israr Ahmad, legal content researcher and founder of AllAboutLawyer.com. Facts verified against official Attorney General announcements from New York and Washington State on September 26, 2026, with limitations noted above. Last Updated: September 26, 2026.

This article is for informational purposes only and does not constitute legal advice. Laws vary by state and individual circumstances differ. For advice about your specific situation, consult a qualified attorney.